The largest database of trusted experimental protocols

14 protocols using k2edta coated tubes

1

Serum TGF-β Levels in CRF Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood samples were collected from 24 healthy volunteers (control) and 120 CRF patients who represented 5 different stages (n=24 in each stage) according to their glomerular filtration rates (GFR): 1 (GFR ≥ 90 mL/min/1.73 m2); 2 (60 < GFR< 89 mL/min/1.73 m2); 3 (30 < GFR< 59 mL/min/1.73 m2); 4 (15 < GFR< 29 mL/min/1.73 m2); and 5 (GFR < 15 mL/min/1.73 m2) 7 (link). All patients were diagnosed with CRF and received therapy in the Department of Nephrology, Jiangxi Provincial People's Hospital, during 2012-2016, and their basic characteristics are summarized in Supplementary Table 1. Blood samples were kept in K2EDTA-coated tubes (BD, Franklin Lakes, NJ, USA, #367835) until use. All participants signed a consent form reviewed and approved by the ethical board of Jiangxi Provincial People's Hospital in China. The serum concentration of TGF-β was determined by an ELISA kit (ThermoFisher Scientific, #BMS249-4).
+ Open protocol
+ Expand
2

PBMC Isolation from Peripheral Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral venous blood was taken into the K2 EDTA coated tubes (BD, Franklin Lakes, NJ). Within one hour of blood draw, PBMCs were isolated as described by Huang et al. [15 (link)]. PBMCs samples were stored at −80 °C until the total RNA extraction.
+ Open protocol
+ Expand
3

Cytokine Profiling in Mouse Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected by either cheek bleed or cardiac puncture in K2EDTA-coated tubes (BD Biosciences). Tubes were centrifuged at 2000 × g for 15 min at 4 °C, and the plasma was collected for analysis. Cytokine levels were evaluated using either the LEGENDplex Mouse Anti-Virus Response Panel (BioLegend) or the LEGENDplex Mouse Cytokine Panel 2 (BioLegend), both with V-bottom plates, according to manufacturer’s instructions, and data were collected using flow cytometry. Cytokine concentrations were interpolated from standard curves using an asymmetric sigmoidal 5-paramater logistic curve fits (GraphPad Prism V10). Bar plots comparing groups and heat maps of averaged values for groups were generated to analyze results.
+ Open protocol
+ Expand
4

Time-course Analysis of AMI Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
All peripheral venous blood samples were obtained from the AMI patients upon admission to Union hospital. The initial blood sample collection time (T0) was 9.24 ± 2.81 h after the onset of AMI symptoms. Subsequent blood samples were obtained at 4 h ± 30 min (4 h), 12 h ± 30 min (12 h), 24 h ± 30 min (24 h), 48 h ± 30 min (48 h), and 72 h ± 30 min (72 h) after T0. Additionally, plasma was collected pre- and post-PCI procedures to investigate whether heparin had an impact on the expression of selected miRNAs in plasma.
All samples (4-8 mL) were collected into K2-EDTA-coated tubes (BD, NJ, USA). The samples were stored for up to 24 h at 4°C and prepared according to the following 2-step centrifugation protocol: 1,500 x g for 15 min at 4°C, then 14,000 x g at 4°C for another 15 min. After centrifugation, the supernatant (plasma) was aliquoted into RNase/DNase-free tubes and stored at −80°C for subsequent experiments.
+ Open protocol
+ Expand
5

Plasma Collection for Transgenic Mouse Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
12-week old male C57BL/6 mice were purchased from Jackson Laboratories. All animal work was performed in accordance with the University of Southern California Institutional Animal Care and Use Committee and Animal Research Committee (ARC) protocols of the University of California, Los Angeles and according to NIH guidelines. Mice were intraperitoneally injected for 20 days with recombinant human IGF-I (rhIGF-I) at 500 μg/kg/day (BID) and recombinant human (rhGH) at 2 mg/kg/day. Following 20 days of rhGH and rhIGF-I treatment, blood collected in K2-EDTA coated tubes (BD, USA) by cardiac puncture at the time of euthanasia were immediately centrifuged for 10 minutes at 1,500 x g using a refrigerated centrifuge to obtain plasma. Plasma from 16 week-old male LID mice, 16-week old female PEPCK-bGH mice, 24-week old male Ames mice, 11-week old male IGFBP-3 KO (BP3KO) mice, and their respective age- and sex-matched matched controls were collected using the same procedures. All genetically altered mice were of the C57BL/6 background.
+ Open protocol
+ Expand
6

Isolation and Immunophenotyping of Murine Leukocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was collected into K2EDTA coated tubes (BD, cat# 365973) from mice by tail nick 2 days after the last intraperitoneal injection of depleting or control antibodies. The Buffy coat was isolated by spinning blood at 800×g at room temperature for 10 min and removing the small layer of the buffy coat. Any carryover red blood cells were lysed using Pharmlyse (BD, 5 min) and quenching with FACS buffer (DPBS supplemented with 2% FCS and 2% HEPES). Cells were washed and stained with BV711 conjugated anti-mouse CD8a (clone53-6.7, Biolegend, 1:200, cat# 563046), PE-conjugated anti-mouse CD4 (clone RM4-5, Biolegend, 1:200, cat# 116006), and APC conjugated anti-mouse NKp46 (clone 29A1.4, Biolegend, 1:200, cat# 137607). Cells were washed three times before staining with DAPI. Data were collected using the BD LSR Fortessa (FACSDiva 8.0.1).
+ Open protocol
+ Expand
7

Isolation and Analysis of Hybrid Circulating Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors were diced and digested for 30 min at 37°C in DMEM + Collagenase A (2 mg/ml; Roche) + DNase (Roche) under stirring conditions. Digested tumor cells were filtered through a 40-μm filter and washed with PBS. For FACS isolation, hybrid and unfused cells were isolated by direct fluorescence on a Becton Dickinson InFlux sorter. For flow cytometric analysis, blood was collected retro-orbitally using heparinized microhematocrit capillary tubes (Fisher) into K2EDTA-coated tubes (BD Biosciences). RBC lysis was performed as described above. Cells were washed and resuspended in FACS buffer (PBS, 1.0 mM EDTA, and 5% FBS). Cells were incubated in PBS containing LIVE/DEAD Fixable Aqua (1:500; Invitrogen) with Fc Receptor Binding Inhibitor (1:200; eBioscience). Cells were then incubated in FACS buffer for 30 min with CD45-PeCy7 (1:8000; BioLegend), CSF1R-BV711 (1:200; BioLegend), F4/80-APC (1:400; BioLegend), and CD11b-AF700 (1:200; eBioscience). A BD LSRFortessa FACS machine was used for analyses. A statistical significance of P < 2.2 × 10−6 by unpaired t test was determined for CD45+ hybrid CTCs relative to CD45 hybrid, CD45+ unfused, and CD45 unfused CTCs. Technical duplicates of n = 5 or 6 mice were analyzed.
+ Open protocol
+ Expand
8

Plasma Cytokine Profiling in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected from the submandibular vein of all experimental mice into K2EDTA-coated tubes (BD Biosciences, 365974) and immediately placed on ice. The blood was centrifuged for 15 minutes at 900g and 4°C, and plasma was collected. Aliquots of plasma were diluted twofold in PBS and stored at –80 °C. Blood plasma cytokines were analysed through a commercially available multiplex panel including Eotaxin, G-CSF, GM-CSF, IFN-γ, IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17A, IP-10, CXCL1, LIF, LIX, MCP-1, M-CSF, MIG, MIP-1alpha, MIP-1beta, MIP-2, RANTES, TNF-α, and VEGF (Eve Technologies, Alberta, Canada, MD-31).
+ Open protocol
+ Expand
9

Plasma Collection from Genetically Altered Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
12-week-old male C57BL/6 mice were purchased from Jackson Laboratories. All animal work was performed in accordance with the University of Southern California Institutional Animal Care and Use Committee and Animal Research Committee (ARC) protocols of the University of California, Los Angeles and according to NIH guidelines. Mice were intraperitoneally injected for 20 days with recombinant human IGF-I (rhIGF-I) at 500 μg kg−1 day−1 (BID) and recombinant human (rhGH) at 2 mg kg−1 day−1. Following 20 days of rhGH and rhIGF-I treatment, blood collected in K2-EDTA coated tubes (BD, Franklin Lakes, NJ, USA) by cardiac puncture at the time of euthanasia were immediately centrifuged for 10 min at 1500 g using a refrigerated centrifuge to obtain plasma. Plasma from 16-week-old male LID mice, 16-week-old female PEPCK-bGH mice, 24-week-old male Ames mice, 11-week-old male IGFBP-3 KO (BP3KO) mice, and their respective age- and sex-matched matched controls were collected using the same procedures. All genetically altered mice were of the C57BL/6 background.
+ Open protocol
+ Expand
10

Cytokine Profiling in Murine Blood and Peritoneal Fluid

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood obtained control and experimental mice was collected in K2EDTA-coated tubes (365974, BD Sciences, ON Canada). The blood was centrifuged for 15 min at 900 g and 4°C, plasma was then isolated, aliquoted and stored at −80°C. Using a mouse multiplex cytokine and chemokine array (MD31; Eve Technologies, Calgary, AB, Canada), cytokines were analyzed using the same mouse panel described above. Peritoneal lavage fluid (PF) was collected at the time of sacrifice via peritoneal lavage with 5 mL of ice-cold PBS and immediately put on ice. PF was centrifuged for 5 min at 400 g and 4°C, then PF was aliquoted and stored at −80°C. Cytokines were assessed with the same mouse multiplex cytokine and chemokine array as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!